Niti K Mann, DO | |
39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 | |
(510) 795-3000 | |
Not Available |
Full Name | Niti K Mann |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 22 Years |
Location | 39400 Paseo Padre Pkwy, Fremont, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285706028 | NPI | - | NPPES |
00AX87540 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 20A8754 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital - Fremont | Fremont, CA | Hospital |
Kaiser Foundation Hospital - San Leandro | San leandro, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & SideguardĀ® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
When signals between the brain and one eye go awry, input from the other eye can become predominant, a condition called amblyopia or "lazy eye."
Researchers in the U.S. say that babies born by Caesarean section rather than normal birth, are three times more likely to die.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system ("CNS"), today reported its financial results for the three and nine months ended September 30, 2010.
› Verified 5 days ago
Entity Name | Permanente Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & SideguardĀ® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
When signals between the brain and one eye go awry, input from the other eye can become predominant, a condition called amblyopia or "lazy eye."
Researchers in the U.S. say that babies born by Caesarean section rather than normal birth, are three times more likely to die.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system ("CNS"), today reported its financial results for the three and nine months ended September 30, 2010.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Niti K Mann, DO 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Niti K Mann, DO 39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 Ph: (510) 795-3000 |
News Archive
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & SideguardĀ® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
When signals between the brain and one eye go awry, input from the other eye can become predominant, a condition called amblyopia or "lazy eye."
Researchers in the U.S. say that babies born by Caesarean section rather than normal birth, are three times more likely to die.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system ("CNS"), today reported its financial results for the three and nine months ended September 30, 2010.
› Verified 5 days ago
Shambhavi Iyer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Karuna Gudur, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Tabassum Alam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
David T. Chiu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Savitha Sundararaj, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Mayura Suryanarayan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 |